Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes

Heather Personett May, PharmD, Erin F Barreto, PharmD, Kristin C. Mara, MS., Kristen McCullough, PharmD, Nelson Leung, MD, Thomas M. Habermann, MD

Blood (2019) 134 (Supplement_1): 1628.

https://doi.org/10.1182/blood-2019-131149

Published: 2019

Journal Articles

A Phase II Non-Randomized Study to Evaluate the Efficacy of Single Dose Rasburicase (1.5mg) in Adult Acute Leukemia and High Grade Lymphomas with Established Tumor Lysis Syndrome

Jayshree Thorat, MD, Swaratika Majumdar, MDDM, Hasmukh Jain, MD DM, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Bhausaheb Bagal, MD DM, Manju Sengar, MD DM

Blood (2019) 134 (Supplement_1): 2914.

https://doi.org/10.1182/blood-2019-128755

Published: 2019

Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2268.

https://doi.org/10.1182/blood-2019-124737

Published: 2019

Journal Articles

Rates of Laboratory Adverse Events By Chemotherapy Course for Pediatric Acute Leukemia Patients within the Leukemia Electronic Abstraction of Records Network (LEARN)

Tamara P. Miller, MD MSc, Kelly D Getz, Biniyam Demissei, MD PhD, Karen R. Rabin, MD PhD, Marla Daves, MD, Philip J. Lupo, PhD MPH, Michael E. Scheurer, PhD MPH, Evanette Burrows, MPH, Brian T. Fisher, DO, MSCE, Robert W. Grundmeier, MD, Judy Lee, Jennifer J. Wilkes, MDMSCE, Lena E. Winestone, MD, Maria Monica J. Gramatges, MD PhD, Richard Aplenc, MD PhD

Blood (2019) 134 (Supplement_1): 333.

https://doi.org/10.1182/blood-2019-130656

Published: 2019

Journal Articles

Use of Routine Bloodwork on General Internal Medicine Inpatients: A Retrospective Cohort Study

William K Silverstein, MD, Adina S. Weinerman, MD MHSc, FRCPC, Rick Wang, MMath, Lisa K. Hicks, MD MSc, R. Sacha Bhatia, MD MBA, FRCPC, Wendy Levinson, MD OC, Fahad Razak, MD MSc, FRCPC, Amol Verma, MD MPhil, FRCPC

Blood (2019) 134 (Supplement_1): 56.

https://doi.org/10.1182/blood-2019-124219

Published: 2019

Journal Articles

Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

Lamis K. Eldjerou, MD, Christopher Acker, BS, Damien Howick, MSc, Lee Clough, RN, Miriam Fuchs, MD PhD, Florence Salmon, PhD, Jennifer Willert, MD, Ranjan Tiwari, MSc, Mayo Pujols, MS, Matthew Robson, MD

Blood (2019) 134 (Supplement_1): 5066.

https://doi.org/10.1182/blood-2019-127346

Published: 2019

Journal Articles

Serum Electrolyte Dynamics in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Apoorva Anandan, MD, Pingfu Fu, Merle Kolk, Nicole Ferrari, Arash Rashidi, MD, Melissa Copley, PharmD, James Driscoll, MD PhD, Paolo Caimi, MD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 5646.

https://doi.org/10.1182/blood-2019-122057

Published: 2019

Journal Articles

Factor-Associated Risk Factors of Mild Cognitive Impairment in Thalassemia Patients : Probable Role of FGF21

Wasan Theerajangkhaphichai, MD, Adisak Tantiworawit, MD, Jirapas Sripetchwandee, PhD, Nattayaporn Apaijai, PhD, Sirawit Sriwichaiin, MD, Napatsorn Saiyasit, Kewarin Jinawong, Busarin Arunsak, Pokpong Piriyakhuntorn, MD, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD PhD, Ekarat Rattarittamrong, MD, Lalita Norasetthada, MD, Pimlak Charoenkwan, MD, Nipon Chattipakorn, MD PhD, Siriporn Chattipakorn, DDS, PhD

Blood (2019) 134 (Supplement_1): 2251.

https://doi.org/10.1182/blood-2019-125182

Published: 2019

Journal Articles

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Karin Melanie Cabanillas Stanchi, MSc, Julia Vek, Dr. MD, Patrick Schlegel, MD, Christian M. Seitz, MD, Joachim Rupprecht, Dr. MD, Sarah Schober, Dr. MD, Sebastian Michaelis, Dr. MD, Carmen Malaval, Dr. MD, Tim Flaadt, Dr. MD, Lukas Schnaufer, Dr. MD, Manon Queudeville, Dr. MD, Judith Feucht, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2018-99-112762

Published: 2018

Journal Articles

Assessment of Iron Overload Impact on QTc Interval in Patients with Sickle Cell Disease

Gilbert Bader, MD, Gregory J. Kato, MD, Suvankar Majumdar, MBCHB, James Pollard, MD, Jarrod Knudson, MD, Neil Shannon, Tanyanan Tanawuttiwat, MD, Clinton Carroll, MD, Joseph Maher, MD

Blood (2018) 132 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2018-99-115125

Published: 2018

Journal Articles

Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients

Lasse H. Jakobsen, Fredrik Ellin, Knut B. Smeland, Tove Wästerlid, Jacob H. Christensen, Judit Jørgensen, MD PhD, Pär L. Josefsson, Harald Holte, Jr., MD PhD, Yngvild N. Blaker, Jacob H. Grauslund, Jon Bjørn, Daniel Molin, Ingemar Lagerlöf, MD, Karin Ekstroem Smedby, MDPhD, Katherine Colvin, Gita Thanarajasingam, MD, Alina S. Gerrie, MD MPH, Chan Y. Cheah, Tarec C. El-Galaly

Blood (2018) 132 (Supplement 1): 452.

https://doi.org/10.1182/blood-2018-99-111748

Published: 2018

Journal Articles

NEPA (netupitant + palonosetron) Administration Is Safe and Effective in cHL Patients Receiving ABVD Regimen: A Single-Center Real Life Experience

Vittorio Ruggero Zilioli, Periana Minga, Lara Crucitti, Erika Meli, Monica Luigia Torretta, Anna Esposito, Chiara Rusconi, Roberto Cairoli

Blood (2018) 132 (Supplement 1): 5374.

https://doi.org/10.1182/blood-2018-99-116543

Published: 2018

Journal Articles

Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post Bone Marrow Transplant: Single Center Experience and Systematic Review

Hwazen A Shash, MD, Saad Aldaama, MD, Ghufran A Al-Hawaj, MSN, Abdullah M Alfareed, MD, Sameera A Alafghani, MD

Blood (2018) 132 (Supplement 1): 5694.

https://doi.org/10.1182/blood-2018-99-115808

Published: 2018

Journal Articles

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Blood (2018) 132 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2018-99-120049

Published: 2018

Journal Articles

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Vladan Vucinic, MD, Sabine Leiblein, PhD, Kristina Schakols, MD, Claudia Nehring, MD, Yvonne Remane, PhD, Madlen Jentzsch, MD, Sebastian Schwind, MD, Wolfram Pönisch, MD, Runa Stiegler, MD, Constanze Kliem, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2018) 132 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2018-99-118531

Published: 2018

Journal Articles

Enasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial

Eytan M. Stein, MD, Abigail Shoben, Uma Borate, MD, Maria R. Baer, MD, Wendy Stock, MD, Prapti A. Patel, MD, Tibor Kovacsovics, MD, William Blum, MD, Jo-Anne Vergilio, MD, Nyla A. Heerema, PhD, Leonard Rosenberg, Sonja Marcus, MPH, Mona Stefanos, MBChB, Jordan Chervin, Brian J. Druker, MD, Amy Burd, PhD, John C. Byrd, MD, Ross L. Levine, MD, Alice S. Mims, MD

Blood (2018) 132 (Supplement 1): 287.

https://doi.org/10.1182/blood-2018-99-118287

Published: 2018

Journal Articles

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Mahesh Swaminathan, MD, Hagop M. Kantarjian, MD, Naval Daver, MD, Gautam Borthakur, MD, Maro Ohanian, DO, Tapan Kadia, MD, Courtney D. DiNardo, MDMSc, Nitin Jain, MD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, William G Wierda, MD PhD, Farhad Ravandi, MBBS, Maria Rhona Pinsoy, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 723.

https://doi.org/10.1182/blood.V130.Suppl_1.723.723

Published: 2017

Journal Articles

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

Osama Tanous, MD, Yossi Azulay, MD, Tal Dujovny, MD, Netta Schwarz, PhD, Raul Colodner, PhD, Ariel Koren, MD, Carina Levin, MDPhD

Blood (2017) 130 (Supplement 1): 949.

https://doi.org/10.1182/blood.V130.Suppl_1.949.949

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation at Home

Anthony D. Sung, MD, Krista R. Nichols, RN, MSN, AOCNS, Julia A. Messina, MD, Kristi Romero, BA, Tara Dalton, MBS, Amy Bush, BA, Megan Covington, BS, Rebecca Shelby, PhD, Jennifer Frith, RN, MSN, OCN, Cristina J. Gasparetto, MD, Mitchell E. Horwitz, MD, Gwynn D. Long, MD, Richard Lopez, MD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith M. Sullivan, MD, Nelson J. Chao, MDM.B.A

Blood (2017) 130 (Supplement 1): 745.

https://doi.org/10.1182/blood.V130.Suppl_1.745.745

Published: 2017

Journal Articles

Bvgp: A Novel Protocol for Hodgkin's with Excellent Response, Minimal Acute Toxicities and Reduced Risk of Late Effects

Bruce Bostrom, MD, Nathan Gossai, MD, Joanna Lee Perkins, MPH, MD, Michael Richards, MD PhD, Yoav H. Messinger, MD

Blood (2017) 130 (Supplement 1): 5192.

https://doi.org/10.1182/blood.V130.Suppl_1.5192.5192

Published: 2017

NARROW

Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes

A Phase II Non-Randomized Study to Evaluate the Efficacy of Single Dose Rasburicase (1.5mg) in Adult Acute Leukemia and High Grade Lymphomas with Established Tumor Lysis Syndrome

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Rates of Laboratory Adverse Events By Chemotherapy Course for Pediatric Acute Leukemia Patients within the Leukemia Electronic Abstraction of Records Network (LEARN)

Use of Routine Bloodwork on General Internal Medicine Inpatients: A Retrospective Cohort Study

Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

Serum Electrolyte Dynamics in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Factor-Associated Risk Factors of Mild Cognitive Impairment in Thalassemia Patients : Probable Role of FGF21

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Assessment of Iron Overload Impact on QTc Interval in Patients with Sickle Cell Disease

Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients

NEPA (netupitant + palonosetron) Administration Is Safe and Effective in cHL Patients Receiving ABVD Regimen: A Single-Center Real Life Experience

Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post Bone Marrow Transplant: Single Center Experience and Systematic Review

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Enasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

Hematopoietic Stem Cell Transplantation at Home

Bvgp: A Novel Protocol for Hodgkin's with Excellent Response, Minimal Acute Toxicities and Reduced Risk of Late Effects

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only